| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |